ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Self-reported voice symptoms in e-cigarette users: a cross-sectional study.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundElectronic cigarette (e-cigarette) use has risen sharply, particularly among young adults who tend to view vaping as safer than conventional smoking. The larynx and vocal folds sit directly in the path of inhaled aerosols, yet the impact of e-cigarette use on voice remains poorly described, particularly in Saudi Arabia.
objectiveTo assess self-reported voice handicap among current, former, and never e-cigarette users in Saudi Arabia using the Voice Handicap Index-10 (VHI-10), and to examine factors linked to abnormal voice scores.
methodsAn online cross-sectional survey of 1,445 adults was carried out across Saudi Arabia from July to August 2025. Participants were categorized by smoking status as current e-cigarette users, former users, conventional smokers, or never smokers. The survey collected data on demographics, smoking behavior, and voice handicap using the VHI-10. Statistical analysis included t-tests, chi-square tests, Pearson correlations, and multivariable logistic regression.
resultsFormer e-cigarette users recorded higher VHI-10 scores (3.9 ± 6.9) than current users (2.2 ± 4.7, p = 0.002). Multivariable logistic regression revealed that former users had higher odds of abnormal voice scores than current users (OR = 1.85, 95% CI: 1.04–3.36, p = 0.038). Current users reported longer duration of use, higher daily consumption, and higher nicotine concentration. Perceptions of e-cigarette risks differed across groups, with current users more likely to rate vaping as less harmful.
conclusionE-cigarette use relates to measurable self-reported voice handicap, and former users report more vocal difficulties than current users. This pattern may reflect consistent with more noticeable symptoms among former users or limited awareness of vocal problems among individuals who continue to vape. LEVEL OF EVIDENCE: level 4. This study is Level 4 evidence because it is observational, crosssectional, and lacks randomization, followup, or the ability to determine causality. It relies on selfreported subjective data (VHI10) with limited control of confounders, and it is not a cohort study, RCT, or systematic review.
Indexed as
Identifiers
41735553What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.